Analysts' Actions: ACN BBBY OC PANW VRSK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Accenture ( ACN) was downgraded at UBS to neutral from buy and given a $77 price target. The stock has a rich multiple and is no longer a tech standout, said UBS.

Bed Bath & Beyond ( BBBY) was upgraded at Bank of America/Merrill Lynch to buy. $82 price target. Company deserves a higher multiple and estimates were also boosted, BofA/Merrill said.

Citizens Community Bancorp ( CZWI) was downgraded to hold at TheStreet Ratings.

Owens Corning ( OC) was downgraded at Citigroup to neutral from buy and given a $43 price target. Roofing EBIT expectations have been reduced, Citi said.

Lihua International ( LIWA) was downgraded to hold at TheStreet Ratings.

Palo Alto ( PANW) was initiated with an outperform rating at Oppenheimer. $47 price target. Company should benefit from solid trends in the security market, Oppenheimer said.

Verisk Analytics ( VRSK) was initiated with a buy rating at Deutsche Bank. $65 price target. Company has low volatility and can deliver solid organic growth, Deutsche Bank said.

STOCK COMMENTS/EPS CHANGES

Accenture numbers were cut at Citigroup. Estimates were reduced given the outlook guide-down, said Citigroup. Given the higher cash balance, however, the price target was raised to $84.50, Citi added.

Accenture estimates, price target were reduced at Jefferies. Shares are now seen reaching $71. Estimates were also cut, given the company's new guidance, Jefferies said. Hold rating.

KB Home ( KBH) price target and estimates were increased at UBS. Earnings estimates were raised on margin outperformance and great-than-expected average selling price growth, said UBS. Price target goes to $14.

KB Home estimates were increased at JMP Securities through 2014. Company is realizing higher gross margins, JMP Securities said. Market Perform rating.

Lorillard ( LO) numbers were raised at Citigroup. Encouraging fundamentals of analog and e-cigarettes, said Citigroup. Price target goes to $46.

Nike ( NKE) estimates were cut at UBS. Earnings estimates were reduced given the shift in expenses and lower-than-expected share buybacks, said UBS.

Paychex ( PAYX) numbers were reduced at UBS. Minimal leverage and a difficult demand backdrop, said UBS.

Walgreen ( WAG) estimates were lowered at Credit Suisse through 2014. Underlying fundamentals remain lackluster, Credit Suisse said. Neutral rating and $45 price target.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Novo Nordisk Stock Rises 4% Over 2 Sessions

Novo Nordisk Stock Rises 4% Over 2 Sessions

Stock Market Just Took Another Beating -- Here's What You Need to Know

Stock Market Just Took Another Beating -- Here's What You Need to Know

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins